These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11011993)

  • 1. Gastric retention and stability of lipidized Bowman-Birk protease inhibitor in mice.
    Wang J; Shen WC
    Int J Pharm; 2000 Aug; 204(1-2):111-6. PubMed ID: 11011993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of the Bowman Birk protease inhibitor in mice following oral administration.
    Billings PC; St Clair WH; Maki PA; Kennedy AR
    Cancer Lett; 1992 Mar; 62(3):191-7. PubMed ID: 1596863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of pharmacokinetic parameters of a polypeptide, the Bowman-Birk protease inhibitor (BBI), and its palmitic acid conjugate.
    Honeycutt L; Wang J; Ekrami H; Shen WC
    Pharm Res; 1996 Sep; 13(9):1373-7. PubMed ID: 8893277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polylysine conjugates of Bowman-Birk protease inhibitor as targeted anti-carcinogenic agents.
    Persiani S; Yeung A; Shen WC; Kennedy AR
    Carcinogenesis; 1991 Jun; 12(6):1149-52. PubMed ID: 2044199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Bowman-Birk inhibitor from soybeans as an anticarcinogenic agent.
    Kennedy AR
    Am J Clin Nutr; 1998 Dec; 68(6 Suppl):1406S-1412S. PubMed ID: 9848508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary excretion of Bowman-Birk inhibitor in humans after soy consumption as determined by a monoclonal antibody-based immunoassay.
    Wan XS; Lu LJ; Anderson KE; Ware JH; Kennedy AR
    Cancer Epidemiol Biomarkers Prev; 2000 Jul; 9(7):741-7. PubMed ID: 10919746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bowman-Birk protease inhibitor and its palmitic acid conjugate prevent 7,12-dimethylbenz[a]anthracene-induced transformation in cultured mouse mammary glands.
    Du X; Beloussow K; Shen WC
    Cancer Lett; 2001 Mar; 164(2):135-41. PubMed ID: 11179827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-dose administration of Bowman-Birk inhibitor concentrate in patients with oral leukoplakia.
    Armstrong WB; Kennedy AR; Wan XS; Atiba J; McLaren CE; Meyskens FL
    Cancer Epidemiol Biomarkers Prev; 2000 Jan; 9(1):43-7. PubMed ID: 10667462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biodistribution of Bowman-Birk soybean protease inhibitor conjugate with amphiphilic polyester.
    Larionova NI; Gladysheva IP; Polekhina OV; Kurochkina LP; Gorbatova EN
    Appl Biochem Biotechnol; 1996; 61(1-2):139-48. PubMed ID: 9100351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of Bowman-Birk inhibitor and anti-Bowman-Birk inhibitor antibodies in sera of humans and animals treated with Bowman-Birk inhibitor concentrate.
    Wan XS; Serota DG; Ware JH; Crowell JA; Kennedy AR
    Nutr Cancer; 2002; 43(2):167-73. PubMed ID: 12588697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The protease inhibitor, Bowman-Birk Inhibitor, suppresses experimental autoimmune encephalomyelitis: a potential oral therapy for multiple sclerosis.
    Gran B; Tabibzadeh N; Martin A; Ventura ES; Ware JH; Zhang GX; Parr JL; Kennedy AR; Rostami AM
    Mult Scler; 2006 Dec; 12(6):688-97. PubMed ID: 17262995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of dimethylhydrazine-induced carcinogenesis in mice by dietary addition of the Bowman-Birk protease inhibitor.
    St Clair WH; Billings PC; Carew JA; Keller-McGandy C; Newberne P; Kennedy AR
    Cancer Res; 1990 Feb; 50(3):580-6. PubMed ID: 2297699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of spermine-conjugated Bowman-Birk inhibitor (spermine-BBI) on carcinogenesis and cholesterol biosynthesis in mice.
    Kennedy AR; Kritchevsky D; Shen WC
    Pharm Res; 2003 Dec; 20(12):1908-10. PubMed ID: 14725352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo anti-inflammatory efficacy of the combined Bowman-Birk trypsin inhibitor and genistein isoflavone, two biological compounds from soybean.
    Sadeghalvad M; Mohammadi-Motlagh HR; Karaji AG; Mostafaie A
    J Biochem Mol Toxicol; 2019 Dec; 33(12):e22406. PubMed ID: 31593353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soybean Bowman-Birk protease inhibitor (BBI): identification of the mechanisms of BBI suppressive effect on growth of two adenocarcinoma cell lines: AGS and HT29.
    Fereidunian A; Sadeghalvad M; Oscoie MO; Mostafaie A
    Arch Med Res; 2014 Aug; 45(6):455-61. PubMed ID: 25014623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bowman-Birk protease inhibitor from the seeds of Vigna unguiculata forms a highly stable dimeric structure.
    Rao KN; Suresh CG
    Biochim Biophys Acta; 2007 Oct; 1774(10):1264-73. PubMed ID: 17869196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies related to the potential antigenicity of the Bowman-Birk inhibitor, an anticarcinogenic protease inhibitor isolated from soybeans.
    Maki PA; Paterson Y; Kennedy AR
    Nutr Cancer; 1994; 22(2):185-93. PubMed ID: 14502847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disposition of positively charged Bowman-Birk protease inhibitor conjugates in mice: influence of protein conjugate charge density and size on lung targeting.
    Ekrami H; Kennedy AR; Shen WC
    J Pharm Sci; 1995 Apr; 84(4):456-61. PubMed ID: 7629736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of lung tumor development in mice with the soybean-derived Bowman-Birk protease inhibitor.
    Witschi H; Kennedy AR
    Carcinogenesis; 1989 Dec; 10(12):2275-7. PubMed ID: 2591017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heat-induced inactivation mechanisms of Kunitz trypsin inhibitor and Bowman-Birk inhibitor in soymilk processing.
    Chen Y; Xu Z; Zhang C; Kong X; Hua Y
    Food Chem; 2014 Jul; 154():108-16. PubMed ID: 24518322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.